Cardiovascular risks and primary interventions among treated rheumatoid arthritis patients: Experience from a tertiary care centre in Kuala Lumpur, Malaysia

Purpose: To investigate the cardiovascular risk among treated rheumatoid arthritis (RA) patients to predict factors associated with high and determine presence of pharmacotherapy primary prevention RA disease (CVD) risk.Methods: The study was a prospective cross-sectional on adult diagnosed for without established heart disease/stroke. Cardiovascular scoring based Framingham Disease 10-year prediction model (BMI model) x 1.5 factor while descriptive inferential analyses were done using SPSS.Results: High CVD defined as FRS-CVD categories (>20%) 55.9% at risk. Use Hydroxychloroquine (OR: 0.44; 95 % CI: 0.21- 0.92; p= 0.028) COX-2 inhibitors 0.31; 95% CI:0.10- 0.95; p = 0.039) found be significantly patients. Significant number did receive (p 0.001).Conclusion: are independent negative predictors Baseline data may useful in rational use medications treat RA, considering that related mortality is leading cause death RA.